{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T15:58:29Z","timestamp":1785772709718,"version":"3.56.0"},"reference-count":37,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:00:00Z","timestamp":1612915200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Context<\/jats:title>\n                  <jats:p>Psychiatric symptoms are common in Cushing\u2019s disease (CD) and seem only partly reversible following treatment.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To investigate drug dispenses associated to psychiatric morbidity in CD patients before treatment and during long-term follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Nationwide longitudinal register-based study.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Setting<\/jats:title>\n                  <jats:p>University Hospitals in Sweden.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Subjects<\/jats:title>\n                  <jats:p>CD patients diagnosed between 1990 and 2018 (N = 372) were identified in the Swedish Pituitary Register. Longitudinal data was collected from 5 years before, at diagnosis, and during follow-up. Four matched controls per patient were included. Cross-sectional subgroup analysis of 76 patients in sustained remission was also performed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main outcome measures<\/jats:title>\n                  <jats:p>Data from the Swedish Prescribed Drug Register and the Patient Register.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the 5-year period before and at diagnosis, use of antidepressants (odds ratio [OR] 2.2 [95% confidence interval (CI) 1.3-3.7]) and 2.3 [1.6-3.5]), anxiolytics [2.9 (1.6-5.3) and 3.9 (2.3-6.6)], and sleeping pills [2.1 (1.2-3.7) and 3.8 (2.4-5.9)] was more common in CD than controls. ORs remained elevated at 5-year follow-up for antidepressants [2.4 (1.5-3.9)] and sleeping pills [3.1 (1.9-5.3)]. Proportions of CD patients using antidepressants (26%) and sleeping pills (22%) were unchanged at diagnosis and 5-year follow-up, whereas drugs for hypertension and diabetes decreased. Patients in sustained remission for median 9.3 years (interquartile range 8.1-10.4) had higher use of antidepressants [OR 2.0 (1.1-3.8)] and sleeping pills [2.4 (1.3-4.7)], but not of drugs for hypertension.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Increased use of psychotropic drugs in CD was observed before diagnosis and remained elevated regardless of remission status, suggesting persisting negative effects on mental health. The study highlights the importance of early diagnosis of CD, and the need for long-term monitoring of mental health.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1210\/clinem\/dgab079","type":"journal-article","created":{"date-parts":[[2021,2,11]],"date-time":"2021-02-11T07:37:34Z","timestamp":1613029054000},"page":"1750-1760","source":"Crossref","is-referenced-by-count":30,"title":["Psychotropic Drugs in Patients with Cushing\u2019s Disease Before Diagnosis and at Long-Term Follow-Up: A Nationwide Study"],"prefix":"10.1210","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4408-6435","authenticated-orcid":false,"given":"Daniel","family":"Bengtsson","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Kalmar, Region of Kalmar County, Kalmar, Sweden"},{"name":"Department of Biomedical and Clinical Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0204-9492","authenticated-orcid":false,"given":"Oskar","family":"Ragnarsson","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2488-0375","authenticated-orcid":false,"given":"Katarina","family":"Berinder","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Karolinska University Hospital, Stockholm, Sweden"},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6471-9503","authenticated-orcid":false,"given":"Per","family":"Dahlqvist","sequence":"additional","affiliation":[{"name":"Department of Public Health and Clinical Medicine, Ume\u00e5 University, Ume\u00e5, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4514-5193","authenticated-orcid":false,"given":"Britt","family":"Ed\u00e9n Engstr\u00f6m","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, Endocrinology and Mineral Metabolism, Uppsala University, Uppsala, Sweden"},{"name":"Department of Endocrinology and Diabetes, Uppsala University Hospital, Uppsala, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8732-7361","authenticated-orcid":false,"given":"Bertil","family":"Ekman","sequence":"additional","affiliation":[{"name":"Department of Endocrinology in Link\u00f6ping and Department of Health, Medicine and Caring Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3980-1927","authenticated-orcid":false,"given":"Charlotte","family":"H\u00f6ybye","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Karolinska University Hospital, Stockholm, Sweden"},{"name":"Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4844-8336","authenticated-orcid":false,"given":"Pia","family":"Burman","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Sk\u00e5ne University Hospital, University of Lund, Malm\u00f6, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9456-2044","authenticated-orcid":false,"given":"Jeanette","family":"Wahlberg","sequence":"additional","affiliation":[{"name":"Department of Endocrinology in Link\u00f6ping and Department of Health, Medicine and Caring Sciences, Link\u00f6ping University, Link\u00f6ping, Sweden"},{"name":"Faculty of Medical Sciences, \u00d6rebro University, \u00d6rebro, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2021,2,10]]},"reference":[{"issue":"9996","key":"2021122205031221100_CIT0001","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing\u2019s syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet."},{"issue":"2","key":"2021122205031221100_CIT0002","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s11102-015-0645-6","article-title":"Comorbidities in Cushing\u2019s disease","volume":"18","author":"Sharma","year":"2015","journal-title":"Pituitary."},{"issue":"7","key":"2021122205031221100_CIT0003","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing\u2019s syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"6","key":"2021122205031221100_CIT0004","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1210\/jc.2018-02524","article-title":"Overall and disease-specific mortality in patients with Cushing disease: A Swedish Nationwide Study","volume":"104","author":"Ragnarsson","year":"2019","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122205031221100_CIT0005","first-page":"137","article-title":"The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism)","volume":"50","author":"Cushing","year":"1932","journal-title":"Bull Johns Hopkins Hosp."},{"issue":"191","key":"2021122205031221100_CIT0006","first-page":"465","article-title":"Psychiatric manifestations of Cushing\u2019s syndrome: response to lowering of plasma cortisol","volume":"48","author":"Jeffcoate","year":"1979","journal-title":"Q J Med."},{"issue":"1","key":"2021122205031221100_CIT0007","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00006842-198102000-00002","article-title":"Depressed mood and other psychiatric manifestations of Cushing\u2019s syndrome: relationship to hormone levels","volume":"43","author":"Starkman","year":"1981","journal-title":"Psychosom Med."},{"issue":"5-6","key":"2021122205031221100_CIT0008","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000182736","article-title":"Course of depression in Cushing\u2019s syndrome: response to treatment and comparison with Graves\u2019 disease","volume":"39","author":"Sonino","year":"1993","journal-title":"Horm Res."},{"issue":"3","key":"2021122205031221100_CIT0009","first-page":"912","article-title":"The longitudinal course of psychopathology in Cushing\u2019s syndrome after correction of hypercortisolism","volume":"82","author":"Dorn","year":"1997","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021122205031221100_CIT0010","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000029054","article-title":"Clinical correlates of major depression in Cushing\u2019s disease","volume":"31","author":"Sonino","year":"1998","journal-title":"Psychopathology."},{"key":"2021122205031221100_CIT0011","doi-asserted-by":"crossref","first-page":"129","DOI":"10.3389\/fnins.2015.00129","article-title":"Neuropsychiatric disorders in Cushing\u2019s syndrome","volume":"9","author":"Pivonello","year":"2015","journal-title":"Front Neurosci."},{"issue":"8","key":"2021122205031221100_CIT0012","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s40265-017-0735-z","article-title":"Psychiatric symptoms in patients with Cushing\u2019s Syndrome: prevalence, diagnosis and management","volume":"77","author":"Santos","year":"2017","journal-title":"Drugs."},{"issue":"5","key":"2021122205031221100_CIT0013","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2165\/00023210-200115050-00003","article-title":"Psychiatric disorders associated with Cushing\u2019s syndrome. Epidemiology, pathophysiology and treatment","volume":"15","author":"Sonino","year":"2001","journal-title":"CNS Drugs."},{"issue":"Suppl 1","key":"2021122205031221100_CIT0014","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000314317","article-title":"Neuropsychiatric disorders in Cushing\u2019s syndrome","volume":"92","author":"Pereira","year":"2010","journal-title":"Neuroendocrinology."},{"issue":"6","key":"2021122205031221100_CIT0015","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1046\/j.1365-2265.1996.8690878.x","article-title":"A prospective study of psychiatric and psychological aspects of Cushing\u2019s syndrome","volume":"45","author":"Kelly","year":"1996","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"10","key":"2021122205031221100_CIT0016","doi-asserted-by":"crossref","first-page":"E129","DOI":"10.1210\/jc.2010-0512","article-title":"Increased prevalence of psychopathology and maladaptive personality traits after long-term cure of Cushing\u2019s disease","volume":"95","author":"Tiemensma","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"2021122205031221100_CIT0017","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1530\/EJE-12-0308","article-title":"Impaired quality of life in patients in long-term remission of Cushing\u2019s syndrome of both adrenal and pituitary origin: a remaining effect of long-standing hypercortisolism?","volume":"167","author":"Wagenmakers","year":"2012","journal-title":"Eur J Endocrinol."},{"issue":"9","key":"2021122205031221100_CIT0018","doi-asserted-by":"crossref","first-page":"E1640","DOI":"10.1210\/jc.2012-1945","article-title":"Long-term cognitive impairments and attentional deficits in patients with Cushing\u2019s disease and cortisol-producing adrenal adenoma in remission","volume":"97","author":"Ragnarsson","year":"2012","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021122205031221100_CIT0019","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/cen.13600","article-title":"Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing\u2019s disease than patients with cortisol producing adenoma. Data from the ERCUSYN","volume":"88","author":"Valassi","year":"2018","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2021122205031221100_CIT0020","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11102-019-00951-1","article-title":"The incidence of Cushing\u2019s disease: a nationwide Swedish study","volume":"22","author":"Ragnarsson","year":"2019","journal-title":"Pituitary."},{"issue":"5","key":"2021122205031221100_CIT0021","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing\u2019s syndrome: an Endocrine Society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab."},{"key":"2021122205031221100_CIT0022","volume-title":"Swedish Prescribed Drug Registry","year":"2019"},{"issue":"7","key":"2021122205031221100_CIT0023","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register: opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"2021122205031221100_CIT0024","volume-title":"Swedish National Patient Registry","year":"2019"},{"key":"2021122205031221100_CIT0025","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health."},{"issue":"2","key":"2021122205031221100_CIT0026","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/joim.13056","article-title":"Psychiatric and neurocognitive consequences of endogenous hypercortisolism","volume":"288","author":"Piasecka","year":"2020","journal-title":"J Intern Med."},{"issue":"3","key":"2021122205031221100_CIT0027","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ecl.2013.05.010","article-title":"Neuropsychiatric findings in Cushing syndrome and exogenous glucocorticoid administration","volume":"42","author":"Starkman","year":"2013","journal-title":"Endocrinol Metab Clin North Am."},{"issue":"6","key":"2021122205031221100_CIT0028","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrn1683","article-title":"Stress and the brain: from adaptation to disease","volume":"6","author":"de Kloet","year":"2005","journal-title":"Nat Rev Neurosci."},{"issue":"2","key":"2021122205031221100_CIT0029","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.physbeh.2009.09.008","article-title":"The effects of chronic glucocorticoid exposure on dendritic length, synapse numbers and glial volume in animal models: implications for hippocampal volume reductions in depression","volume":"99","author":"Tata","year":"2010","journal-title":"Physiol Behav."},{"issue":"6","key":"2021122205031221100_CIT0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1530\/EJE-13-0471","article-title":"Smaller grey matter volumes in the anterior cingulate cortex and greater cerebellar volumes in patients with long-term remission of Cushing\u2019s disease: a case-control study","volume":"169","author":"Andela","year":"2013","journal-title":"Eur J Endocrinol."},{"key":"2021122205031221100_CIT0031","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.nicl.2014.01.017","article-title":"Widespread reductions of white matter integrity in patients with long-term remission of Cushing\u2019s disease","volume":"4","author":"van der Werff","year":"2014","journal-title":"Neuroimage Clin."},{"issue":"8","key":"2021122205031221100_CIT0032","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing\u2019s Syndrome: An Endocrine Society Clinical Practice Guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021122205031221100_CIT0033","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1530\/EJE-16-0779","article-title":"Affective alterations in patients with Cushing\u2019s syndrome in remission are associated with decreased BDNF and cortisone levels","volume":"176","author":"Valassi","year":"2017","journal-title":"Eur J Endocrinol."},{"key":"2021122205031221100_CIT0034","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz136","article-title":"Time to diagnosis in Cushing\u2019s syndrome: a meta-analysis based on 5367 patients","author":"Rubinstein","year":"2020;105(3):13","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2021122205031221100_CIT0035","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1530\/EJE-14-0766","article-title":"From first symptoms to final diagnosis of Cushing\u2019s disease: experiences of 176 patients","volume":"172","author":"Kreitschmann-Andermahr","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2021122205031221100_CIT0036","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1530\/EJE-11-0272","article-title":"The European Registry on Cushing\u2019s syndrome: 2-year experience. baseline demographic and clinical characteristics","volume":"165","author":"Valassi","year":"2011","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2021122205031221100_CIT0037","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/PRA.0000000000000113","article-title":"Cushing disease presenting as primary psychiatric illness: a case report and literature review","volume":"21","author":"Rasmussen","year":"2015","journal-title":"J Psychiatr Pract."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgab079\/36584358\/dgab079.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/6\/1750\/41850926\/dgab079.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/106\/6\/1750\/41850926\/dgab079.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T05:08:14Z","timestamp":1640149694000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/106\/6\/1750\/6132459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,10]]},"references-count":37,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,2,10]]},"published-print":{"date-parts":[[2021,5,13]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgab079","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6,1]]},"published":{"date-parts":[[2021,2,10]]}}}